Article
Clinical utility of comprehensive genomic profiling in non-small cell lung cancer: An analysis of a nation-wide database.
Lung cancer (Amsterdam, Netherlands) - 1 Feb 2025
Fujii Koki, Ueki Michiko, Morishita Momoko, Ikushima Hiroaki, Isago Hideaki, Watanabe Kousuke, Oda Katsutoshi, Kage Hidenori
Abstract excerpt
BACKGROUND: Molecular testing is recommended to patients with advanced non-small cell lung cancer (NSCLC) because those who receive targeted therapy have better prognosis than patients who don't. However, recent studies have raised concerns that first-line companion diagnostic testing at diagnosis may have lower detection rates than previously reported. Therefore, we sought to determine the utility of...
Topics
Join the communities discussing this publication.
